SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-153614
Filing Date
2010-07-02
Accepted
2010-07-02 16:46:32
Documents
3
Period of Report
2010-07-02
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 14629
2 OPINION OF WYRICK ROBBINS YATES & PONTON, LLP dex51.htm EX-5.1 4876
3 SALES AGREEMENT dex1015.htm EX-10.15 204808
  Complete submission text file 0001193125-10-153614.txt   225892
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51462 | Film No.: 10936694
SIC: 2836 Biological Products, (No Diagnostic Substances)